Literature DB >> 18502721

ACE2 and AT4R are present in diseased human blood vessels.

A Zulli1, L M Burrell, B F Buxton, D L Hare.   

Abstract

A growing body of evidence suggests that the angiotensin II fragments, Ang(1-7) and Ang(3-8), have a vasoactive role, however ACE2, the enzyme that produces Ang(1-7), or AT4R, the receptor that binds Ang (3-8), have yet been simultaneously localised in both normal and diseased human conduit blood vessels. We sought to determine the immunohistochemical distribution of ACE2 and the AT4R in human internal mammary and radial arteries from patients undergoing coronary artery bypass surgery. We found that ACE2 positive cells were abundant in both normal and diseased vessels, being present in neo-intima and in media. ACE2 positive immunoreactivity was not present in the endothelial layer of the conduit vessels, but was clearly evident in small newly formed angiogenic vessels as well as the vaso vasorum. Endothelial AT4R immunoreactivity were rarely observed in either normal and diseased arteries, but AT4R positive cells were observed adjacent to the internal elastic lamine in the internal mammary artery, in the neo-intima of radial arteries, as well as in the media of both internal mammary artery and radial artery. AT4R was abundant in vaso vasorum and within small angiogenic vessels. Both AT4R and ACE2 co-localised with smooth muscle cell alpha actin. This study identifies smooth muscle cell alpha actin positive ACE2 and AT4R in human blood vessels as well as in angiogenic vessels, indicating a possible role for these enzymes in pathological disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502721     DOI: 10.4081/1184

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  12 in total

1.  Histochemistry through the years, browsing a long-established journal: novelties in traditional subjects.

Authors:  C Pellicciari
Journal:  Eur J Histochem       Date:  2010-12-16       Impact factor: 3.188

2.  Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.

Authors:  Nicola Ielapi; Noemi Licastro; Michele Provenzano; Michele Andreucci; Stefano de Franciscis; Raffaele Serra
Journal:  Biomark Med       Date:  2020-05-19       Impact factor: 2.851

Review 3.  Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure.

Authors:  Vaibhav B Patel; Brendan Putko; Zuocheng Wang; Jiu-Chang Zhong; Gavin Y Oudit
Journal:  Drug Discov Today Ther Strateg       Date:  2014-01-24

4.  The Effect of an Atherogenic Diet and Acute Hyperglycaemia on Endothelial Function in Rabbits Is Artery Specific.

Authors:  Alexander Tacey; Tawar Qaradakhi; Cassandra Smith; Chris Pittappillil; Alan Hayes; Anthony Zulli; Itamar Levinger
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

Review 5.  The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Authors:  Xiaofang Wang; Panpan Yi; Yuejin Liang
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 6.  From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension.

Authors:  Sheila K Patel; Elena Velkoska; Melanie Freeman; Bryan Wai; Terase F Lancefield; Louise M Burrell
Journal:  Front Physiol       Date:  2014-06-24       Impact factor: 4.566

7.  Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.

Authors:  Jay Ramchand; Sheila K Patel; Piyush M Srivastava; Omar Farouque; Louise M Burrell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

8.  Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques.

Authors:  Anthony Zulli; Sudarshan Rai; Brian F Buxton; Louise M Burrell; David L Hare
Journal:  Exp Physiol       Date:  2008-01-11       Impact factor: 2.969

9.  Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.

Authors:  Richard E Gilbert; Lauren Caldwell; Paraish S Misra; Kin Chan; Kevin D Burns; Jeffrey L Wrana; Darren A Yuen
Journal:  Can J Diabetes       Date:  2020-07-18       Impact factor: 4.190

Review 10.  SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

Authors:  Natalijia Novak; Wenming Peng; Mirjam C Naegeli; Christina Galvan; Isabel Kolm-Djamei; Charlotte Brüggen; Beatriz Cabanillas; Peter Schmid-Grendelmeier; Alba Catala
Journal:  Allergy       Date:  2020-08-12       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.